Ultragenyx Pharmaceutical (RARE) Shares Outstanding (Diluted) (2017 - 2026)

Ultragenyx Pharmaceutical (RARE) Shares Outstanding (Diluted) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 255.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 106.00 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 64.41 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.51 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 556.90 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 138.28 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 Ultragenyx Pharmaceutical 2.61 Bn 2.33 Bn 180.00 Mn 101.90 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 101.90 Mn
Mar 31, 2026 100.60 Mn
Dec 31, 2025 98.60 Mn
Sep 30, 2025 99.77 Mn
Jun 30, 2025 98.46 Mn
Mar 31, 2025 96.29 Mn
Dec 31, 2024 90.54 Mn
Sep 30, 2024 95.49 Mn
Jun 30, 2024 86.58 Mn
Mar 31, 2024 84.29 Mn
Dec 31, 2023 73.54 Mn
Sep 30, 2023 71.66 Mn
Jun 30, 2023 70.90 Mn
Mar 31, 2023 70.37 Mn
Dec 31, 2022 69.91 Mn
Sep 30, 2022 70.05 Mn
Jun 30, 2022 69.93 Mn
Mar 31, 2022 69.52 Mn
Dec 31, 2021 67.80 Mn
Sep 30, 2021 67.88 Mn